Stocktoria

ACHIEVE LIFE SCIENCES, INC. ACHV

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-12 · LEI

ACHIEVE LIFE SCIENCES, INC. financials (annual)

Revenue
$0 $0 2016201720182019202020212022202320242025
Net income
-$1.2M -$10.6M -$12.7M -$16.4M -$14.7M -$33.2M -$42.4M -$29.8M -$39.8M -$54.6M 2016201720182019202020212022202320242025
Free cash flow
-$248000 -$10.7M -$15.3M -$13.5M -$24.5M -$49.5M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$0$0
R&D expense$22.8M$15.8M$30.1M$24.0M$6.9M$9.7M$5.9M$3.1M$286,000
Interest expense$2.9M$1.8M
Income tax$0
Net income-$54.6M-$39.8M-$29.8M-$42.4M-$33.2M-$14.7M-$16.4M-$12.7M-$10.6M-$1.2M
EPS (diluted)$-1.25$-1.24$-1.50$-4.00$-4.08$-5.42
Operating cash flow-$49.5M-$29.8M-$24.5M-$37.6M-$29.4M-$13.5M-$15.2M-$10.6M-$9.1M-$202,000
Free cash flow-$49.5M-$24.5M-$13.5M-$15.3M-$10.7M-$248,000
Cash & equivalents$20.9M$12.8M$15.5M$24.8M$43.0M$35.9M$16.7M$9.5M$5.3M$15,000
Total assets$41.8M$38.6M$19.4M$30.0M$47.5M$40.3M$21.1M$19.1M$9.9M$3.8M
Total liabilities$20.3M$17.7M$20.8M$21.7M$19.5M$3.0M$3.0M$3.3M$2.0M$3.2M
Shareholders' equity$21.5M$20.9M-$1.4M$8.3M$28.0M$37.3M$18.1M$15.8M$15.8M$610,000

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.